Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hartmann

Showing results (581-590 of 626) with videos related to

Pageof 63
Sort By:
Journal of the National Cancer Institute|April 5, 2017
Breast Cancer Risk and Progressive Histology in Serial Benign BiopsiesDaniel W Visscher, Ryan D Frank, Jodi M Carter, et al.
Proceedings. Biological Sciences|August 17, 2018
Before platelets: the production of platelet-activating factor during growth and stress in a basal marine organismInes Galtier d'Auriac, Robert A Quinn, Heather Maughan, et al.
BMC Cancer|June 9, 2009
Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancerKristin L White, Robert A Vierkant, Catherine M Phelan, et al.
Journal of the National Cancer Institute|October 2, 2014
Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancerGottfried E Konecny, Chen Wang, Habib Hamidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapyLynn C Hartmann, Karen H Lu, Gerald P Linette, et al.
Journal of the National Cancer Institute|November 8, 2001
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriersL C Hartmann, T A Sellers, D J Schaid, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer familiesT A Sellers, R A King, J R Cerhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Novel breast tissue feature strongly associated with risk of breast cancerKevin P McKian, Carol A Reynolds, Daniel W Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Stratification of breast cancer risk in women with atypia: a Mayo cohort studyAmy C Degnim, Daniel W Visscher, Hal K Berman, et al.
BMC Cancer|February 2, 2017
Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohortRobert A Vierkant, Amy C Degnim, Derek C Radisky, et al.
Pageof 63

Showing results (581-590 of 626) with videos related to

Sort By:
Pageof 63
Journal of the National Cancer Institute|April 5, 2017
Breast Cancer Risk and Progressive Histology in Serial Benign BiopsiesDaniel W Visscher, Ryan D Frank, Jodi M Carter, et al.
Proceedings. Biological Sciences|August 17, 2018
Before platelets: the production of platelet-activating factor during growth and stress in a basal marine organismInes Galtier d'Auriac, Robert A Quinn, Heather Maughan, et al.
BMC Cancer|June 9, 2009
Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancerKristin L White, Robert A Vierkant, Catherine M Phelan, et al.
Journal of the National Cancer Institute|October 2, 2014
Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancerGottfried E Konecny, Chen Wang, Habib Hamidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapyLynn C Hartmann, Karen H Lu, Gerald P Linette, et al.
Journal of the National Cancer Institute|November 8, 2001
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriersL C Hartmann, T A Sellers, D J Schaid, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer familiesT A Sellers, R A King, J R Cerhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Novel breast tissue feature strongly associated with risk of breast cancerKevin P McKian, Carol A Reynolds, Daniel W Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Stratification of breast cancer risk in women with atypia: a Mayo cohort studyAmy C Degnim, Daniel W Visscher, Hal K Berman, et al.
BMC Cancer|February 2, 2017
Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohortRobert A Vierkant, Amy C Degnim, Derek C Radisky, et al.
Pageof 63